NPS on new drugs
THE latest edition of Australian Prescriber from NPS MedicineWise highlights three new drugs on the Australian market.
Brexpiprazole (Rexulti from Lundbeck) is a new antipsychotic for schizophrenia, is structurally similar to aripiprazole and has a similar mechanism of action.
Somavert (pegvisomant) by Pfizer binds to growth hormone receptors and is indicated for acromegaly as a powder for reconstitution.
Thirdly, NPS writes up Gilead’s Epculsa (sofosbuvir-velpatasvir fixed combination) for hepatitis C.
Visit nps.org.au for details.